Publisher Correction Issued for Study on Streptococcus pyogenes Immunity in Children
A correction has been published regarding the research article “Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting,” detailing author affiliations.The study, investigating the development of immunity to Streptococcus pyogenes – a bacterium responsible for diseases like strep throat and invasive infections – in a high-incidence setting, involved a collaborative effort across multiple international institutions.
The corrected affiliations are as follows: Clare E. Turner & Thurshan I. Silva are affiliated with the School of Biosciences, University of Sheffield, Sheffield, UK. Alexander J. Keeley, Edwin P. Armitage, Beate Kampmann, and Michael Marks are with the Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK. Edwin P. Armitage also has an affiliation with Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. Gabrielels the Crombroughs, Pierre R. Smorle, and anne Botteaux are associated with both the Molecular Bacteriology Laboratory, European Plotkin Institute for Vaccinology, Université Libre de Bruxelles, Brussels, Belgium, and the Department of Paediatrics, Brussels University Hospital, Academic Children Hospital Queen Fabiola, Université Libre de Bruxelles, Brussels, Belgium. Alana L. Whitcombe and Nicole J. Moreland are affiliated with the Faculty of Medical and Health Sciences, The University of Auckland, auckland, New Zealand. Martina Carducci, Luca Rovetini, Elena Boero, Luisa Massai, Miren Iturriza, Danilo Gomes Moriel, and Omar Rossi are with GSK Vaccines Institute for Global Health (GVGH), Siena, Italy. Adam Kucharski is with the Center for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, london, UK.Beate Kampmann also has an affiliation with the Charity Center for Global Health, Charity – Universitätsmedizin Berlin, Berlin, Germany. Michael Marks is also affiliated with the Hospital for Tropical Diseases, University College london Hospital, London, UK, and the Division of Infection and Immunity, University College London, London, UK. Henrik Salje is with the Department of Genetics,University of Cambridge,cambridge,UK.
Streptococcus pyogenes remains a meaningful global health concern, notably in regions with high rates of infection. Understanding the development of natural immunity is crucial for informing vaccine strategies and public health interventions aimed at reducing the burden of disease. The original research sought to characterize antibody responses to S. pyogenes in early life, providing insights into how protective immunity develops naturally in populations where exposure is frequent.